HY FDA AT MY FACILITY IS, AND WHAT DO I DO DURING 2016 - Conference on why FDA at my Facility is, and what do I do During an Inspection
View: 315
Website http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900549SEMINAR |
Edit Freely
Category FDA inspection ,Regulatory & Compliance,regulatory and compliance requirements
Deadline: July 19, 2016 | Date: July 21, 2016-July 22, 2016
Venue/Country: Zurich, Switzerland, Switzerland
Updated: 2016-05-10 20:08:00 (GMT+9)
Call For Papers - CFP
Course "Why is FDA at my Facility, and What do I do During an Inspection" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.Overview:Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer. This presentation will review and emphasize the do's and don'ts and cardinal rules as to interviewing, how to respond, reviewing documentation, etiquette, use of certain words, body language, responding to questions/requests, etc., and certainly replying to 483's and Warning Letters. Emphasis is placed on the company's SOP on dealing with inspectors and knowing how to be prepared, proactive...and being able to defend and justify... and what it takes to achieve a favorable outcome. This seminar provides background and understanding of the role played by the Agency, its administrative and enforcement powers. It takes the participant step by step through the entire inspection process and describes various types of inspections.Who will benefit:Industries• FDA regulated Industrieso Medical Deviceo Pharmaceuticalso Clinical• Dietary Supplementso Foodo Nutraceutical• Healthcare ITo Technical Serviceso Validationo EngineeringDepartments• Top and Middle Management• Quality Assurance/Management• Compliance Management• Manufacturing• Laboratory• Regulatory Affairs• Information Technology• Marketing & Sales• Operations• Research & DevelopmentTypes of facilities:• Manufacturing facilities• Contract manufacturing facilities• Distributors• Packaging, Labeling• API Suppliers• Laboratories• Importers• Documentation ManagementAgenda:Day 1 ScheduleLecture 1:How a firm should prepare for an FDA inspectionLecture 2:Ways to train employees in view of the inspectionLecture 3:How to ensure that required documentation is in placeLecture 4:How to interact with the investigator-DO's and DON'T'sLecture 5:What companies should do when the inspection endsLecture 6:How to reply to 483's and warning lettersLecture 7:Legal implications of non-complianceLecture 8:Post inspection actionsDay 2 ScheduleLecture 1:Why inspections are conducted and by what statutory authorityLecture 2:The emphasis on systems-based inspections...and the IOM and other crucial FDA reference documentsLecture 3:What is subject to FDA purview and what's off-limitsLecture 4:Understand and apply the do's and don'ts and comprehend that preparation is the key to successLecture 5:What are the prohibited "Acts" and the enforcement categories that you need to deal withLecture 6:What you need to know and do to prepare for, during and even after the inspection...and why your inspection response team is keyLecture 7:The company's Inspection Plan (SOP) can make or break the inspection depending on how to use it and training your personnelLecture 8:How to respond to findings and facilitating the documentation and remediation process...and reaching final closureLecture 9:Define clear responsibilities, roles and goals for personnel involved in SOP developmentSpeaker:David R DillsRegulatory Affairs & Compliance Consultant,David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses global regulatory requirements. Location: Zurich, Switzerland Date: July 21st and 22nd, 2016 and Time: 9:00 AM to 6:00 PMVenue: WILL BE ANNOUNCED SOON Price:Register now and save $200. (Early Bird)Price: $1,695.00 (Seminar Fee for One Delegate – Without stay)Until June 20, Early Bird Price: $1,695.00 from June 21 to July 19, Regular Price: $1,895.00 Price: $2,095.00 (Seminar Fee for One Delegate - With stay)Until June 20, Early Bird Price: $2,095.00 from June 21 to July 19, Regular Price: $2,295.00Quick Contact:NetZealous DBA as GlobalCompliancePanel Phone: 1-800-447-9407Fax: 302-288-6884Email: supportglobalcompliancepanel.com Website: http://www.globalcompliancepanel.comRegistration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900549SEMINAR Follow on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.